Dana FilotiSenior Scientist at Abbvie
Dana Filoti is currently a member of the NBE Analytical R&D group at AbbVie, where she leads the analytical clinical development of ADC therapeutics along with preclinical candidate selection, drug delivery systems and subvisible particle characterization of protein therapeutics. She received her Ph.D. in Physics/Materials Science from University of New Hampshire. As a Genentech Post-Doctoral fellow, she worked with Dr. Thomas Laue at the Biomolecular Interaction Technologies Center (BITC) on the development of instrumentation and methods for examining macromolecular interactions via charge measurements to address colloidal stability issues associated with high concentration formulation development. She has 9 years experience in protein formulation, analytical development and biophysical characterization.